1. CD25-targeted antibody–drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity. Issue 2 (10th September 2020) Authors: Zammarchi, Francesca; Havenith, Karin; Bertelli, Francois; Vijayakrishnan, Balakumar; Chivers, Simon; van Berkel, Patrick H Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗